Electronic prescribing (e-Prescribing) is a key component to improving patient safety and reducing medication errors, because it provides real-time clinical decision support to physicians at the time of order entry. It is estimated that approximately 7,000 deaths occur each year in the United States from preventable medication errors. That is why physician adoption of e-Prescribing has been incentivized by the federal government. However, one of the biggest challenges surrounding physician’s adoption of e-Prescribing is the ability for them to electronically transmit prescriptions for controlled substances.
Prior to June 2010, all controlled substance prescriptions were required to be on paper, so instead of maintaining one process for paper-based controlled substances and another that is electronically based for noncontrolled substances; physicians were choosing to stick with a paper-based prescription process. In an effort to remove this headache and extra work that was required by physcians there was a new ruling made by the US Drug Enforcement Administration (DEA) to encourage physicians adoption. In June 2010, the DEA revised the Code of Federal Regulations to allow the electronic transmission of schedule II-V controlled substances to pharmacies. Now physicians can migrate to an electronic system and not worry about maintaining a separate paper-based system.
Lexi-Data is the foundation of Lexicomp's comprehensive clinical decision support database and it contains federal CSA codes as well as a list of state level overrides that e-Prescribing systems need to make this happen.
Lexicomp will be exhibiting at HIMSS 2012 in Las Vegas from February 20 - 24. Stop by for a visit at Booth #5134 and learn more about the preferred choice of drug information databases!